Therapeutic effect of Xue Niao An on glyoxylate-induced calcium oxalate crystal deposition based on urinary metabonomics approach

The anti-nephrolithiasis effect of Xue Niao An (XNA) capsules is explored by analyzing urine metabolic profiles in mouse models, with ultra-high performance liquid chromatography quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF/MS). An animal model of calcium oxalate crystal renal deposition was established in mice by intra-abdominal injection of glyoxylate. Then, treatment with XNA by intra-gastric administration was performed. At the end of the study, calcium deposition in kidney was measured by Von Kossa staining under light microscopy, and the Von Kossa staining changes showed that XNA significantly alleviated the calcium oxalate crystal deposition. Meanwhile, urine samples for fifteen metabolites, including amino acids and fatty acids, with significant differences were detected in the calcium oxalate group, while XNA treatment attenuated metabolic imbalances. Our study indicated that the metabonomic strategy provided comprehensive insight on the metabolic response to XNA treatment of rodent renal calcium oxalate deposition.

[1]  E. Rimm,et al.  History of kidney stones and the risk of coronary heart disease. , 2013, JAMA.

[2]  Y. Uwai,et al.  Transport of Xanthurenic Acid by Rat/Human Organic Anion Transporters OAT1 and OAT3 , 2013, Bioscience, biotechnology, and biochemistry.

[3]  S. Mohamed,et al.  Evaluation of biochemical effects of Casuarina equisetifolia extract on gentamicin-induced nephrotoxicity and oxidative stress in rats. Phytochemical analysis , 2013, Journal of clinical biochemistry and nutrition.

[4]  Ying-yong Zhao.  Metabolomics in chronic kidney disease. , 2013, Clinica chimica acta; international journal of clinical chemistry.

[5]  S. Niida,et al.  NMR-based metabolomics of urine in a mouse model of Alzheimer’s disease: identification of oxidative stress biomarkers , 2013, Journal of clinical biochemistry and nutrition.

[6]  Saeed R. Khan.  Reactive oxygen species as the molecular modulators of calcium oxalate kidney stone formation: evidence from clinical and experimental investigations. , 2013, The Journal of urology.

[7]  O. Kjartansson,et al.  Temporal trends in the incidence of kidney stone disease. , 2013, Kidney international.

[8]  Xu-dong Xu,et al.  Clerodendranoic Acid, a New Phenolic Acid from Clerodendranthus spicatus , 2012, Molecules.

[9]  L. Melton,et al.  Urolithiasis and the risk of ESRD. , 2012, Clinical journal of the American Society of Nephrology : CJASN.

[10]  A. Bello,et al.  Kidney stones and kidney function loss: a cohort study , 2012, BMJ : British Medical Journal.

[11]  Christopher S Saigal,et al.  Prevalence of kidney stones in the United States. , 2012, European urology.

[12]  F. Dias,et al.  The Antioxidant Role of Xanthurenic Acid in the Aedes aegypti Midgut during Digestion of a Blood Meal , 2012, PloS one.

[13]  K. Tozawa,et al.  Mitochondrial permeability transition pore opening induces the initial process of renal calcium crystallization. , 2012, Free radical biology & medicine.

[14]  S. Sadigh-Eteghad,et al.  The Effects of the Hydroalcohol Extract of Rosa canina L. Fruit on Experimentally Nephrolithiasic Wistar Rats , 2012, Phytotherapy research : PTR.

[15]  Edward M. Messing,et al.  Re: Prevalence of Kidney Stones in the United States Scales CD Jr, Smith AC, Hanley JM, Saigal CS, Urologic Diseases in America Project , 2012 .

[16]  Zhiping Wang,et al.  Evaluation of antiurolithic effect and the possible mechanisms of Desmodium styracifolium and Pyrrosiae petiolosa in rats , 2012, Urological Research.

[17]  Saeed R. Khan.  Is oxidative stress, a link between nephrolithiasis and obesity, hypertension, diabetes, chronic kidney disease, metabolic syndrome? , 2012, Urological Research.

[18]  W. R. Wikoff,et al.  Untargeted metabolomics identifies enterobiome metabolites and putative uremic toxins as substrates of organic anion transporter 1 (Oat1). , 2011, Journal of proteome research.

[19]  Jian Zuo,et al.  Effect of NADPH oxidase inhibition on the expression of kidney injury molecule and calcium oxalate crystal deposition in hydroxy-L-proline-induced hyperoxaluria in the male Sprague-Dawley rats. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[20]  Young-S. Kim,et al.  Ameliorating effects of Mango (Mangifera indica L.) fruit on plasma ethanol level in a mouse model assessed with 1H-NMR based metabolic profiling , 2011, Journal of clinical biochemistry and nutrition.

[21]  J. Lieske,et al.  1,2,3,4,6-Penta-O-galloyl-beta-D-glucose reduces renal crystallization and oxidative stress in a hyperoxaluric rat model. , 2011, Kidney international.

[22]  Yan Lu,et al.  Aristolochic acid-induced destruction of organic ion transporters and fatty acid metabolic disorder in the kidney of rats. , 2011, Toxicology letters.

[23]  Yu Cao,et al.  Metabonomic evaluation of melamine-induced acute renal toxicity in rats. , 2010, Journal of proteome research.

[24]  Eric J Bergstralh,et al.  Kidney stones and the risk for chronic kidney disease. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[25]  A. IJzerman,et al.  Adenosine A1 Receptor Binding Activity of Methoxy Flavonoids from Orthosiphon stamineus , 2009, Planta medica.

[26]  G. Remuzzi,et al.  Propionyl-L-carnitine prevents early graft dysfunction in allogeneic rat kidney transplantation. , 2008, Kidney international.

[27]  G. Scheffer,et al.  Renal xenobiotic transporters are differentially expressed in mice following cisplatin treatment. , 2008, Toxicology.

[28]  D. Zorov,et al.  The role of mitochondria in oxidative and nitrosative stress during ischemia/reperfusion in the rat kidney. , 2007, Kidney international.

[29]  Salim S. Al-Rejaie,et al.  REVERSAL OF CISPLATIN‐INDUCED CARNITINE DEFICIENCY AND ENERGY STARVATION BY PROPIONYL‐l‐CARNITINE IN RAT KIDNEY TISSUES , 2007, Clinical and experimental pharmacology & physiology.

[30]  A. Enomoto,et al.  Roles of Organic Anion Transporters in the Progression of Chronic Renal Failure , 2007, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

[31]  S. Nigam,et al.  Drug and toxicant handling by the OAT organic anion transporters in the kidney and other tissues , 2007, Nature Clinical Practice Nephrology.

[32]  Atsushi Okada,et al.  Successful formation of calcium oxalate crystal deposition in mouse kidney by intraabdominal glyoxylate injection , 2007, Urological Research.

[33]  Saeed R. Khan.  Role of Renal Epithelial Cells in the Initiation of Calcium Oxalate Stones , 2004, Nephron Experimental Nephrology.

[34]  M. Menon,et al.  Molecular Mechanism of Oxalate-Induced Free Radical Production and Glutathione Redox Imbalance in Renal Epithelial Cells: Effect of Antioxidants , 2004, American Journal of Nephrology.

[35]  I. Wilson,et al.  A metabonomic investigation of the biochemical effects of mercuric chloride in the rat using 1H NMR and HPLC-TOF/MS: time dependent changes in the urinary profile of endogenous metabolites as a result of nephrotoxicity. , 2004, The Analyst.

[36]  N. Perico,et al.  Propionyl-L-carnitine prevents renal function deterioration due to ischemia/reperfusion. , 2002, Kidney international.

[37]  D. Pawlak,et al.  Tryptophan Metabolism via the Kynurenine Pathway in Experimental Chronic Renal Failure , 2002, Nephron.

[38]  A. Peschechera,et al.  Anaplerotic effect of propionyl carnitine in rat heart mitochondria. , 1994, Biochemical and biophysical research communications.

[39]  R. Stocker,et al.  Antioxidant activities of some tryptophan metabolites: possible implication for inflammatory diseases. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[40]  S. Kolvraa,et al.  In vitro studies on the oxidation of medium-chain dicarboxylic acids in rat liver. , 1986, Biochimica et biophysica acta.

[41]  J. Bremer.  Carnitine--metabolism and functions. , 1983, Physiological reviews.

[42]  S. Kolvraa,et al.  On the Biologic Origin of C6-C10-Dicarboxylic and C6-C10-ω-1-Hydroxy Monocarboxylic Acids in Human and Rat with Acyl-CoA Dehydrogenation Deficiencies: in Vitro Studies on the ω- and ω-1-Oxidation of Medium-Chain (C6-C12) Fatty Acids in Human and Rat Liver , 1983, Pediatric Research.

[43]  S. Kolvraa,et al.  On the biologic origin of C6-C10-dicarboxylic and C6-C10-omega-1-hydroxy monocarboxylic acids in human and rat with acyl-CoA dehydrogenation deficiencies: in vitro studies on the omega- and omega-1-oxidation of medium-chain (C6-C12) fatty acids in human and rat liver. , 1983, Pediatric research.

[44]  P. Kolattukudy,et al.  Biosynthesis of the C18 family of cutin acids: omega-hydroxyoleic acid, omega-hydroxy-9,10-epoxystearic acid, 9,10,18-trihydroxystearic acid, and their delta12-unsaturated analogs. , 1973, Biochemistry.

[45]  P. E. Verkade,et al.  Researches on fat metabolism. II. , 1934, The Biochemical journal.